← Evidence map

TrialBritish journal of cancer2019

Sorafenib alone vs. sorafenib plus GEMOX as 1

Eric Assenat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30944458